Clinical Trial Update: DEB-TACE Treatment in 367 Liver Cancer Patients

View source ↗

Summary

A completed clinical trial evaluating drug-eluting bead transarterial chemoembolization (DEB-TACE) with doxorubicin in hepatocellular carcinoma enrolled 367 par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adriamycin (doxorubicin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Liver Cancer | Status: COMPLETED